| Mr Tyler C Goddard, LCSW | |
|
203 E Cobblecreek Dr, Suite 201, Cedar City, UT 84721-8901 | |
| (435) 586-2182 | |
| (866) 833-5153 |
| Full Name | Mr Tyler C Goddard |
|---|---|
| Gender | Male |
| Speciality | Social Worker - Clinical |
| Location | 203 E Cobblecreek Dr, Cedar City, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821161738 | NPI | - | NPPES |
| 1821161738 | Medicaid | UT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 373214-3501 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Tyler C Goddard, LCSW Po Box 2413, Cedar City, UT 84721-2413 Ph: (435) 586-2182 | Mr Tyler C Goddard, LCSW 203 E Cobblecreek Dr, Suite 201, Cedar City, UT 84721-8901 Ph: (435) 586-2182 |
News Archive
WaferGen Biosystems, Inc. a leading developer of state-of-the-art genomic analysis systems, today announced that it is offering an early access program for high-throughput Single Nucleotide Polymorphism Genotyping through its new SmartChip Real-Time PCR System.
A ground-breaking system for predicting how individual patients with HIV and AIDS will respond to different drugs is launched today by RDI, a UK-based not-for-profit research group. The experimental system, called the HIV Treatment Response Prediction System (HIV-TRePS), is available free of charge over the Internet and helps physicians select the best treatment for their patients.
Apricus Biosciences, backed by a revenue-generating CRO business and seeking to leverage its multi-route NexACT® drug delivery technology and internal pipeline through out-licensing partnerships, announced today that the U.S. Food and Drug Administration (FDA) has provided guidance on the clinical requirements for assessing the approvability of RayVa for the treatment of Raynaud's syndrome secondary to scleroderma.
Past randomized clinical trials have shown that non-steroidal anti-inflammatory drugs (NSAIDs), including naproxen, can reduce the risk of colon cancer and precancerous polyps in humans. Now, researchers at Fox Chase Cancer Center have found that an investigational form of naproxen, called nitric oxide-donating naproxen (NO-naproxen), can block one of the earliest molecular changes that lead to colorectal cancer development while also reducing gastrointestinal toxicity, a relatively common side effect associated with NSAIDs.
› Verified 7 days ago
Carol Marie Rowley, LCSW, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 158 Monterey Dr, Cedar City, UT 84720 Phone: 608-658-8368 | |
Mr. Brent Hinton Judd, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 775 S 1175 W, Cedar City, UT 84720 Phone: 435-586-0535 Fax: 435-586-4914 | |
Nateasa Lynn Mcguire, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2202 N Main St Ste 301, Cedar City, UT 84721 Phone: 319-541-4485 | |
Julee Loces, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 2069 N Main St Ste 101, Cedar City, UT 84721 Phone: 435-267-4212 | |
Mr. Delynn T Lamb, MSW, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 6484 N 2300 W, Cedar City, UT 84721 Phone: 435-867-4876 | |
Mr. Tyson Bruce Terry, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2202 N Main St Ste 301, Cedar City, UT 84720 Phone: 435-586-4479 | |
Kevin Scott Kirschenmann, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 245 E 680 S, Cedar City, UT 84720 Phone: 435-867-7654 Fax: 435-867-7699 |